系统性氧化合成酶抑制与非对称的二甲基亚尔基宁对人类的心血管影响
Jan T Kielstein1, Burcu Impraim, Solveig Simmel
1Department of Internal Medicine, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. kielstein@yahoo.com
Circulation
|December 10, 2003
概括
向健康个体注入不对称的二甲基氨基 (ADMA) 暂时降低了心脏输出和脏血流. 这也增加了全身血管阻力和血压,突出显示了ADMA对心血管的影响.
科学领域:
- 心血管生理学心血管生理学
- 脏生理学 脏生理学
- 内分泌学 在内分泌学.
背景情况:
- 升高的非对称二甲基氨基 (ADMA) 与心血管疾病和病进展有关.
- ADMA是一种内源性氧化合成酶 (NOS) 抑制剂.
研究的目的:
- 评估ADMA输注对健康受试者的系统性心血管影响.
- 通过侵入性方法评估ADMA对心脏输出,功能和血管抵抗的影响.
主要方法:
- 健康的受试者接受了ADMA的静脉注射.
- 使用了侵入性技术,包括右心腔导管和胰岛素/准氨基基酸清除.
- 测量包括心脏输出,全身血管阻力,脏血流量和血压.
主要成果:
- 输入ADMA显著降低了血循环诺辛单酸盐 (cGMP) 水平.
- 心脏输出量下降,而全身血管阻力和血压显著增加.
- 有效的脏血流量减少,血管抵抗增加,表明剂量相关的影响.
结论:
- 系统性ADMA输注会导致心脏输出和脏血流量的短期,适度下降.
- 在剂量取决的方式上,ADMA增加了全身血管阻力和血压.
- 这些发现强调了ADMA对心血管和脏的直接影响.
相关概念视频
Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Antihypertensive Drugs: Vasodilators
2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Antianginal Drugs: Nitrates and β-Blockers
1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
823
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
823
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K


